FDA ACCEPTS BIOGEN’S ADUCANUMAB BIOLOGICS LICENSE APPLICATION FOR ALZHEIMER'S DISEASE

[Adamxd]

investors.biogen.com/news-r...

- Priority Review accelerates FDA review time, with a Prescription Drug User Fee Act (PDUFA) target action on March 7, 2021

- If approved, aducanumab would be the first treatment to meaningfully change the course of Alzheimer’s disease

-Can we say that this is a hope for PSP ? (since both Alzheimer & PSP have so much in common "being taupathies etc..." )

Best regards

[daddyt]

I participated in Biogen's Passport drug trial for PSP - unsuccessful. Tweaking with a few more kicks with their drug just might bring PSP to its knees.

[Adamxd in reply to daddyt]

Thanks Daddyt for your reply,

Indeed, i saw that their "Gosuranemab program" for PSP has failed . i hope this "aducanumab" will bring PSP to its knees as you said .

Hopefully

Best regards

[Adamxd in reply to Adamxd]

reuters.com/article/us-biog...

- Is this a hope for PSP since ALZHEIMER a Taupathy like PSP !! ?